Novo's new insulin pen allows finer-scale adjustments

08/21/2013 | Drug Store News

Novo Nordisk received federal approval for its NovoPen Echo insulin pen, which enables half-unit dosing. The smaller doses allow for more precise adjustments, particularly helpful for treating children with diabetes. The device, the first of its kind in the U.S., also features a memory function that keeps track of dose and time frame between shots.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA